Abstract
A good diet may deliver micronutrients such as vitamins A, B6, B12, C, and D and minerals such as iron, copper, zinc, and selenium that have been implicated to have key roles for supporting immunity with reducing host infections. Most studies have shown that once the subject was infected, the immune system will be enhanced, which will require high levels of metabolic rate, energy requirements, different biosynthesis substances and regulatory molecules, which are obtained from dietary sources. Consequently, a healthy diet will result in a healthy gut by achieving well-balanced gut microbiota which enhances the immune system. The human gut microbiota consists of two major two groups: Firmicutes and Bacteroidetes. Some of these can beneficial, some can be detrimental to the host. Their composition can be modified by small changes in diet when beneficially supports the body’s repair, growth, and immunity. Dietary sources can be converted into beneficial metabolic end-products such as short chain fatty acids, i.e., acetate, propionate, and butyrate, fermented by the beneficial gut microbiota such as Lactobacillus and Bifidobacterium. This is achieved by an indirect nutrient strategy using pro/prebiotic. The gut microbiota cooperates with their hosts for metabolic and nervous systems development, in addition to the function of the immune system regulation via dynamic bidirectional communication known as the gut–brain axis. Indeed, studies have shown a correlation with anxiety, pain, cognition, and mood regulation in animal models studies, related to gut microbiota due to dietary carbohydrates. In addition, specific studies have demonstrated the link of gut microbiota on neurodevelopmental disorders, autism spectrum disorder, and Parkinson diseases. Furthermore, factors such as direct and indirect micronutrients, affecting and the gut–brain microbiome are anticipated with the use of probiotics and prebiotics as functional foods.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aarsland D, Londos E, Ballard C (2009) Parkinson’s disease dementia and dementia with Lewy bodies: different aspects of one entity. Int Psychogeriatr 21(2):216–219. https://doi.org/10.1017/S1041610208008612
Abou-Donia MB, Abou-Donia MM, ElMasry EM, Monro JA, Mulder MF (2013) Autoantibodies to nervous system-specific proteins are elevated in sera of flight crew members: biomarkers for nervous system injury. J Toxicol Environ Health A 76(6):363–380. https://doi.org/10.1080/15287394.2013.765369
Ahern PP, Maloy KJ (2020) Understanding immune-microbiota interactions in the intestine. Immunology 159(1):4–14. https://doi.org/10.1111/imm.13150
Albugami M, Qadi N, Almugbel F, Mohammed A, Alttas A, Elamin A et al (2018) The demographic characteristics and the risk factors of dementia in Saudi elderly. Am J Psychiatry Neurosci 6(1):1–8. https://doi.org/10.11648/j.ajpn.20180601.11
Barichella M, Cereda E, Pezzoli G (2009) Major nutritional issues in the management of Parkinson’s disease. Mov Disord 24(13):1881–1892. https://doi.org/10.1002/mds.22705
Barnett-Cowan M, Dyde RT, Fox SH, Moro E, Hutchison WD, Harris LR (2010) Multisensory determinants of orientation perception in Parkinson’s disease. Neuroscience 167(4):1138–1150. https://doi.org/10.1016/j.neuroscience.2010.02.065
Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J et al (2011a) The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141(2):599–609. https://doi.org/10.1053/j.gastro.2011.04.052
Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X et al (2011b) The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 23(12):1132–1139. https://doi.org/10.1111/j.1365-2982.2011.01796.x
Blumberg R, Powrie F (2012) Microbiota, disease, and back to health: a metastable journey. Sci Transl Med 4:137. https://doi.org/10.1126/scitranslmed.3004184
Boge T, Rémigy M, Vaudaine S, Tanguy J, Bourdet-Sicard R, Werf SV (2009) A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27(41):5677–5684. https://doi.org/10.1016/j.vaccine.2009.06.094
Calder PC (2020) Nutrition, immunity and COVID-19. BMJ Nutr Prev Health 3:74–92. https://doi.org/10.1136/bmjnph-2020-000085
Canitano R, Scandurra V (2008) Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents. Neuropsychiatr Dis Treat 4(4):723–730. https://doi.org/10.2147/ndt.s1450
Carabotti M, Scirocco A, Maselli MA, Severi C (2015) The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 28(2):203–209
Chen C, Brown DR, Xie Y, Green BT, Lyte M (2003) Catecholamines modulate Escherichia coli O157:H7 adherence to murine cecal mucosa. Shock 20(2):183–188. https://doi.org/10.1097/01.shk.0000073867.66587.e0
Collins SM, Surette M, Bercik P (2012) The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 10(11):735–742. https://doi.org/10.1038/nrmicro2876
Davari S, Talaei SA, Alaei H, Salami M (2013) Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis. Neuroscience 240:287–296. https://doi.org/10.1016/j.neuroscience.2013.02.055
Davie CA (2008) A review of Parkinson's disease. Br Med Bull 86:109–127. https://doi.org/10.1093/bmb/ldn013
van De Sande MM, van Buul VJ (2014) Autism and nutrition: the role of the gut–brain axis. Nutr Res Rev 27(2):199–214. https://doi.org/10.1017/S0954422414000110
Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG (2008) The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res 43(2):164–174. https://doi.org/10.1016/j.jpsychires.2008.03.009
Diaz Heijtz R, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A et al (2011) Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 108(7):3047–3052. https://doi.org/10.1073/pnas.1010529108
El-Ansary A, Shaker GH, Rizk MZ (2013) Role of gut-brain axis in the aetiology of neurodevelopmental disorders with reference to autism. J Clin Toxicol S6:005. https://doi.org/10.4172/2161-0495.S6-005
El-Metwally A, Toivola P, Al-Rashidi M, Nooruddin S, Jawed M, AlKanhal R et al (2019) Epidemiology of Alzheimer’s disease and dementia in Arab countries: a systematic review. Behav Neurol 2019:3935943. https://doi.org/10.1155/2019/3935943
Eutamene H, Bueno L (2007) Role of probiotics in correcting abnormalities of colonic flora induced by stress. Gut 56(11):1495–1497. https://doi.org/10.1136/gut.2007.124040
Finegold SM, Molitoris D, Song Y, Liu C, Vaisanen M-L, Bolte E et al (2002) Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 35(Suppl 1):S6–S16. https://doi.org/10.1086/341914
Freestone PP, Williams PH, Haigh RD, Maggs AF, Neal CP, Lyte M (2002) Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in trauma-induced sepsis. Shock 18(5):465–470. https://doi.org/10.1097/00024382-200211000-00014
Galpern WR, Lang AE (2006) Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann Neurol 59(3):449–458. https://doi.org/10.1002/ana.20819
Gareau MG, Jury J, MacQueen G, Sherman PM, Perdue MH (2007) Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 56(11):1522–1528. https://doi.org/10.1136/gut.2006.117176
Gentile CL, Weir TL (2018) The gut microbiota at the intersection of diet and human health. Science 362(6416):776–780. https://doi.org/10.1126/science.aau5812
Ghia J-E, Blennerhassett P, Collins SM (2008) Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest 118(6):2209–2018. https://doi.org/10.1172/JCI32849
Gibson PR, Newnham E, Barrett JS, Shepherd SJ, Muir JG (2007) Review article: fructose malabsorption and the bigger picture. Aliment Pharmacol Ther 25(4):349–363. https://doi.org/10.1111/j.1365-2036.2006.03186.x
Green BT, Lyte M, Kulkarni-Narla, & R, B. D. (2003) Neuromodulation of enteropathogen internalization in Peyer’s patches from porcine jejunum. J Neuroimmunol 141(1–2):74–82. https://doi.org/10.1016/s0165-5728(03)00225-x
Hemarajata P, Versalovic J (2013) Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Ther Adv Gastroenterol 6(1):39–51. https://doi.org/10.1177/1756283X12459294
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B et al (2014) The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506–514. https://doi.org/10.1038/nrgastro.2014.66
Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T et al (2013) Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155(7):1451–1463. https://doi.org/10.1016/j.cell.2013.11.024
Kang D-W, Park JG, Ilhan ZE, Wallstrom G, Labaer J, Adams JB, Krajmalnik-Brown R (2013) Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One 8(7):e68322. https://doi.org/10.1371/journal.pone.0068322
Khalil NA, Walton GE, Gibson GR, Tuohy KM, Andrews SC (2013) In vitro batch cultures of gut microbiota from healthy and ulcerative colitis (UC) subjects suggest that sulphate-reducing bacteria levels are raised in UC and by a protein-rich diet. Int J Food Sci Nutr 65(1):1–10. https://doi.org/10.3109/09637486.2013.825700
Kohane IS, McMurry A, Weber G, MacFadden D, Rappaport L, Kunkel L et al (2012) The co-morbidity burden of children and young adults with autism spectrum disorders. PLoS One 7(4):e33224. https://doi.org/10.1371/journal.pone.0033224
Kolida S, Gibson GR (2007) Prebiotic capacity of inulin-type fructans. J Nutr 137(11 Suppl):2503S–2506S. https://doi.org/10.1093/jn/137.11.2503S
de Lau LM, Breteler MM (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5(6):525–535. https://doi.org/10.1016/S1474-4422(06)70471-9
Ledochowski M, Widner B, Bair H, Probst T, Fuchs D (2000a) Fructose- and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scand J Gastroenterol 35(10):1048–1052. https://doi.org/10.1080/003655200451162
Ledochowski M, Widner B, Sperner-Unterweger B, Propst T, Vogel W, Fuchs D (2000b) Carbohydrate malabsorption syndromes and early signs of mental depression in females. Dig Dis Sci 45(7):1255–1259. https://doi.org/10.1023/a:1005527230346
Ledochowski M, Widner B, Murr C, Sperner-Unterweger B, Fuchs D (2001) Fructose malabsorption is associated with decreased plasma tryptophan. Scand J Gastroenterol 36(4):367–371. https://doi.org/10.1080/003655201300051135
Lomax AR, Calder PC (2009) Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans. Curr Pharm Des 15(13):1428–1518. https://doi.org/10.2174/138161209788168155
Macfarlane GT, Gibson GR, Cummings JH (1992) Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 72(1):57–64. https://doi.org/10.1111/j.1365-2672.1992.tb04882.x
Magnusson KR, Hauck L, Jeffrey BM, Elias V, Humphrey A, Nath R et al (2015) Relationships between diet-related changes in the gut microbiome and cognitive flexibility. Neuroscience 300:128–140. https://doi.org/10.1016/j.neuroscience.2015.05.016
Montiel-Castro AJ, González-Cervantes RM, Bravo-Ruiseco G, Pacheco-López G (2013) The microbiota–gut–brain axis: neurobehavioral correlates, health and sociality. Front Integr Neurosci 7:70. https://doi.org/10.3389/fnint.2013.00070
O’Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho A-M, Quigley EM et al (2009) Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 65(3):263–267. https://doi.org/10.1016/j.biopsych.2008.06.026
Peñagarikano O, Abrahams BS, Herman EI, Winden KD, Gdalyahu A, Dong H et al (2011) Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 147(1):235–246. https://doi.org/10.1016/j.cell.2011.08.040
Persico AM, Napolioni V (2013) Urinary p-cresol in autism spectrum disorder. Neurotoxicol Teratol 36:82–90. https://doi.org/10.1016/j.ntt.2012.09.002
Pickard JM, Zeng MY, Caruso R, Núñez G (2017) Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev 279(1):70–89. https://doi.org/10.1111/imr.12567
Rajeh SA, Bademosi O, Ismail H, Awada A, Dawodu A, Al-Freihi H et al (1993) A community survey of neurological disorders in Saudi Arabia: the Thugbah study. Neuroepidemiology 12(3):164–178. https://doi.org/10.1159/000110316
Round JL, Mazmanian SK (2010) Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 107(27):12204–12209. https://doi.org/10.1073/pnas.0909122107
Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, Tuohy K (2018) Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr 57(1):1–24. https://doi.org/10.1007/s00394-017-1445-8
Salminen SJ, Gueimonde M, Isolauri E (2005) Probiotics that modify disease risk. J Nutr 135(5):1294–1298. https://doi.org/10.1093/jn/135.5.1294
Scott KP, Gratz SW, Sheridan PO, Flint HJ, Duncan SH (2013) The influence of diet on the gut microbiota. Pharmacol Res 69(1):52–60. https://doi.org/10.1016/j.phrs.2012.10.020
Sekirov I, Russel SL, L. C., & Finlay, B. B. (2010) Gut microbiota in health and disease. Physiol Rev 90(3):859–904. https://doi.org/10.1152/physrev.00045.2009
Sender R, Fuchs S, Milo R (2016) Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 14(8):1002533. https://doi.org/10.1371/journal.pbio.1002533
Sengupta U, Guerrero-Muñoz MJ, Castillo-Carranza DL, Lasagna-Reeves CA, Gerson JE, Paulucci-Holthauzen AA et al (2015) Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies. Biol Psychiatry 78(10):672–683. https://doi.org/10.1016/j.biopsych.2014.12.019
Sharon G, Cruz NJ, Kang D-W, Gandal MJ, Wang B, Kim Y-M et al (2019) Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice. Cell 177(6):1600–1618. https://doi.org/10.1016/j.cell.2019.05.004
Shulman JM, Jager PL, Feany MB (2011) Parkinson's disease: genetics and pathogenesis. Annu Rev Pathol 6:193–222. https://doi.org/10.1146/annurev-pathol-011110-130242
Singh RK, Chang H-W, Yan D, Lee KM, Ucmak D, Wong K et al (2017) Influence of diet on the gut microbiome and implications for human health. J Transl Med 15:73. https://doi.org/10.1186/s12967-017-1175-y
Song Y, Liu C, Finegold SM (2004) Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 70(11):6459–6465. https://doi.org/10.1128/AEM.70.11.6459-6465.2004
Steliou K, Boosalis MS, Perrine SP, Sangerman J, Faller DV (2012) Butyrate histone deacetylase inhibitors. BioRes Open Access 1(4):192–198. https://doi.org/10.1089/biores.2012.0223
de Theije CG, Wu J, Silva SL, Kamphuis PJ, Garssen J, Korte SM, Kraneveld AD (2011) Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management. Eur J Pharmacol 668(Suppl 1):S70–S80. https://doi.org/10.1016/j.ejphar.2011.07.013
Thomas CM, Versalovic J (2010) Probiotics-host communication: modulation of signaling pathways in the intestine. Gut Microbes 1(3):148–163. https://doi.org/10.4161/gmic.1.3.11712
Valdes AM, Walter J, Segal E, Spector TD (2018) Role of the gut microbiota in nutrition and health. BMJ 361:k2179. https://doi.org/10.1136/bmj.k2179
Varghese AK, Verdú EF, Bercik P, Khan WI, Blennerhassett PA, Szechtman H, Collins SM (2006) Antidepressants attenuate increased susceptibility to colitis in a murine model of depression. Gastroenterology 130(6):1743–1753. https://doi.org/10.1053/j.gastro.2006.02.007
Wakefield AJ (2002) The gut-brain axis in childhood developmental disorders. J Pediatr Gastroenterol Nutr 34(Suppl 1):S14–S17. https://doi.org/10.1097/00005176-200205001-00004
Willson K, Situ C (2017) Systematic review on effects of diet on gut microbiota in relation to metabolic syndromes. J Clin Nutr Metab 1:2
Wu GD, Chen J, Hoffmann C, Bittinger K, Chen Y-Y, Keilbaugh SA et al (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334(6052):105–108. https://doi.org/10.1126/science.1208344
Young VB (2012) The intestinal microbiota in health and disease. Curr Opin Gastroenterol 28(1):63–69. https://doi.org/10.1097/MOG.0b013e32834d61e9
Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W et al (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464(7285):104–107. https://doi.org/10.1038/nature08780
Zmora N, Suez J, Elinav E (2019) You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol 16(1):35–56. https://doi.org/10.1038/s41575-018-0061-2
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Khalil, N.A., Sarbini, S.R. (2022). Gut–Brain Cross Talk: Microbiome and Micronutrients. In: Mohamed, W., Yamashita, T. (eds) Role of Micronutrients in Brain Health. Nutritional Neurosciences. Springer, Singapore. https://doi.org/10.1007/978-981-16-6467-0_3
Download citation
DOI: https://doi.org/10.1007/978-981-16-6467-0_3
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-6466-3
Online ISBN: 978-981-16-6467-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)